MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus

References

• Caughey AB, Turrentine M. ACOG practice bulletin No. 190 Summary: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):406–408. doi:10.1097/aog.0000000000002498
   Web of Science ®Google Scholar
• Carracher AM, Marathe PH, Close KL. International diabetes federation 2017. J Diabetes. 2018;10(5):353–356. doi:10.1111/1753-0407.12644
   PubMed Web of Science ®Google Scholar
• Mirghani Dirar A, Doupis J. Gestational diabetes from A to Z. World J Diabetes. 2017;8(12):489–511. doi:10.4239/wjd.v8.i12.489
   PubMed Web of Science ®Google Scholar
• Saravanan P, Magee LA, Banerjee A. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020;8(9):793–800. doi:10.1016/s2213-8587(20)30161-3
   PubMed Web of Science ®Google Scholar
• O’Neill S, Bohl M, Gregersen S, Hermansen K, O’Driscoll L. Blood-based biomarkers for metabolic syndrome. Trends Endocrinol Metab. 2016;27(6):363–374. doi:10.1016/j.tem.2016.03.012
   PubMed Web of Science ®Google Scholar
• Morales-Prieto DM, Favaro RR, Markert UR. Placental miRNAs in feto-maternal communication mediated by extracellular vesicles. Placenta. 2020;102:27–33. doi:10.1016/j.placenta.2020.07.001
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Nigi L, Grieco GE, Mancarella F, Ventriglia G, Dotta F. Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? J Endocrinol Invest. 2017;40(6):591–610. doi:10.1007/s40618-017-0611-4
   PubMed Web of Science ®Google Scholar
• Salomon C, Rice GE. Role of exosomes in placental homeostasis and pregnancy disorders. Prog Mol Biol Transl Sci. 2017;145:163–179. doi:10.1016/bs.pmbts.2016.12.006
   PubMed Web of Science ®Google Scholar
• Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: non-coding RNAs and extracellular vesicles–diagnostic and therapeutic implications. Int J Oncol. 2015;46(1):17–27. doi:10.3892/ijo.2014.2712
   Web of Science ®Google Scholar
• Salomon C, Scholz-Romero K, Sarker S, et al. Gestational diabetes mellitus is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestation. Diabetes. 2016;65(3):598–609. doi:10.2337/db15-0966
   PubMed Web of Science ®Google Scholar
• Nardi Fda S, Michelon TF, Neumann J, et al. High levels of circulating extracellular vesicles with altered expression and function during pregnancy. Immunobiology. 2016;221(7):753–760. doi:10.1016/j.imbio.2016.03.001
   Web of Science ®Google Scholar
• Guay C, Regazzi R. New emerging tasks for microRNAs in the control of β-cell activities. Biochim Biophys Acta. 2016;1861(12 Pt B):2121–2129. doi:10.1016/j.bbalip.2016.05.003
   Web of Science ®Google Scholar
• Li C, Qu L, Farragher C, Vella A, Zhou B. MicroRNA regulated macrophage activation in obesity. J Transl Int Med. 2019;7(2):46–52. doi:10.2478/jtim-2019-0011
   Web of Science ®Google Scholar
• Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342. doi:10.3390/ijms19113342
   PubMed Web of Science ®Google Scholar
• McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Prim. 2019;5(1):47. doi:10.1038/s41572-019-0098-8
   PubMed Web of Science ®Google Scholar
• Zhou X, Xiang C, Zheng X. miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability. Diagn Pathol. 2019;14(1):119. doi:10.1186/s13000-019-0899-9
   PubMed Web of Science ®Google Scholar
• Zhao C, Dong J, Jiang T, et al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One. 2011;6(8):e23925. doi:10.1371/journal.pone.0023925
   PubMed Web of Science ®Google Scholar
• Pheiffer C, Dias S, Rheeder P, Adam S. Decreased expression of circulating miR-20a-5p in South African women with gestational diabetes mellitus. Mol Diagn Ther. 2018;22(3):345–352. doi:10.1007/s40291-018-0325-0
   PubMed Web of Science ®Google Scholar
• Qi S, Wang X. Decreased expression of miR-185 in serum and placenta of patients with gestational diabetes mellitus. Clin Lab. 2019;65(12):Dec. doi:10.7754/Clin.Lab.2019.190445
   Web of Science ®Google Scholar
• Guan CY, Tian S, Cao JL, Wang XQ, Ma X, Xia HF. Down-regulated miR-21 in gestational diabetes mellitus placenta induces PPAR-α to inhibit cell proliferation and infiltration. Diabetes Metab Syndr Obes. 2020;13:3009–3034. doi:10.2147/dmso.s253920
   PubMed Web of Science ®Google Scholar
• Deng L, Huang Y, Li L, Chen H, Su J. Serum miR-29a/b expression in gestational diabetes mellitus and its influence on prognosis evaluation. J Int Med Res. 2020;48(9):300060520954763. doi:10.1177/0300060520954763
   Web of Science ®Google Scholar
• Fu S, Fu S, Ma X, Yang X, Ling J. miR‑875‑5p regulates IR and inflammation via targeting TXNRD1 in gestational diabetes rats. Mol Med Rep. 2021;23(5). doi:10.3892/mmr.2021.11942
   Web of Science ®Google Scholar
• Sebastiani G, Guarino E, Grieco GE, et al. Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p. Front Endocrinol (Lausanne). 2017;8:345. doi:10.3389/fendo.2017.00345
   PubMed Web of Science ®Google Scholar
• Wang J, Pan Y, Dai F, Wang F, Qiu H, Huang X. Serum miR-195-5p is upregulated in gestational diabetes mellitus. J Clin Lab Anal. 2020;34(8):e23325. doi:10.1002/jcla.23325
   PubMed Web of Science ®Google Scholar
• Dai S, Zhu X, Xia H. MiR-2467 is a potential marker for prediction of gestational diabetes mellitus in pregnancy. Clin Lab. 2020;66(10). doi:10.7754/Clin.Lab.2020.200233
   Web of Science ®Google Scholar
• Sørensen AE, van Poppel MNM, Desoye G, et al. The predictive value of miR-16, −29a and −134 for early identification of gestational diabetes: a nested analysis of the DALI cohort. Cells. 2021;10(1):170. doi:10.3390/cells10010170
   Web of Science ®Google Scholar
• Liu L, Zhang J, Liu Y. MicroRNA-1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose-induced inhibition of trophoblast cell viability by suppressing TP53INP1. Exp Ther Med. 2021;21(3):230. doi:10.3892/etm.2021.9661
   PubMed Web of Science ®Google Scholar
• Shen H, Sun J, Liu J, Wang L, Dong L. miR-181d promotes pancreatic beta cell dysfunction by targeting IRS2 in gestational diabetes mellitus. Ginekol Pol. 2021;92(8):563–570. doi:10.5603/GP.a2021.0077
   Web of Science ®Google Scholar
• Wen J, Bai X. miR-520h Inhibits cell survival by targeting mTOR in gestational diabetes mellitus. Acta Biochim Pol. 2021;68(1):65–70. doi:10.18388/abp.2020_5389
   PubMed Web of Science ®Google Scholar
• Wang F, Li Z, Zhao M, et al. Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus. Gynecol Endocrinol. 2021;37(7):665–671. doi:10.1080/09513590.2021.1908990
   PubMed Web of Science ®Google Scholar
• Zheng T, Chen H. Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/NOV axis. Mol Immunol. 2021;137:163–173. doi:10.1016/j.molimm.2021.06.011
   PubMed Web of Science ®Google Scholar
• Martínez-Ibarra A, Martínez-Razo LD, Vázquez-Martínez ER, et al. Unhealthy levels of phthalates and bisphenol a in Mexican pregnant women with gestational diabetes and its association to altered expression of miRNAs involved with metabolic disease. Int J Mol Sci. 2019;20(13):3343. doi:10.3390/ijms20133343
   Web of Science ®Google Scholar
• Li HX, Li XH, Jiang J, Shi PX, Zhang XG, Tian M. Effect of miR-26b on gestational diabetes mellitus in rats via PI3K/Akt signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(4):1609–1615. doi:10.26355/eurrev_202002_20335
   Web of Science ®Google Scholar
• Gillet V, Ouellet A, Stepanov Y, et al. miRNA profiles in extracellular vesicles from serum early in pregnancies complicated by gestational diabetes mellitus. J Clin Endocrinol Metab. 2019;104(11):5157–5169. doi:10.1210/jc.2018-02693
   PubMed Web of Science ®Google Scholar
• Shah KB, Chernausek SD, Teague AM, Bard DE, Tryggestad JB. Maternal diabetes alters microRNA expression in fetal exosomes, human umbilical vein endothelial cells and placenta. Pediatr Res. 2021;89(5):1157–1163. doi:10.1038/s41390-020-1060-x
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang T, Sun D, et al. Diagnostic value of dysregulated microribonucleic acids in the placenta and circulating exosomes in gestational diabetes mellitus. J Diabetes Investig. 2021;12(8):1490–1500. doi:10.1111/jdi.13493
   Web of Science ®Google Scholar
• Herrera-van Oostdam AS, Toro-Ortíz JC, López JA, et al. Placental exosomes isolated from urine of patients with gestational diabetes exhibit a differential profile expression of microRNAs across gestation. Int J Mol Med. 2020;46(2):546–560. doi:10.3892/ijmm.2020.4626
   PubMed Web of Science ®Google Scholar
• Nair S, Ormazabal V, Jayabalan N, et al. Circulating exosomal miRNA signature in gestational diabetes mellitus influences glucose metabolism in placental cells. Diabetes. 2018;67(Supplement1):164–LB. doi:10.2337/db18-164-LB
   Web of Science ®Google Scholar
• Zhang Z, Xu Q, Chen Y, et al. The possible role of visceral fat in early pregnancy as a predictor of gestational diabetes mellitus by regulating adipose-derived exosomes miRNA-148 family: protocol for a nested case-control study in a cohort study. BMC Pregnancy Childbirth. 2021;21(1):262. doi:10.1186/s12884-021-03737-1
   PubMed Web of Science ®Google Scholar
• Jayabalan N, Scholz-Romero K, Guanzon D, et al. 1972-P: adipose tissue–derived exosomal microRNA regulates placental glucose uptake in gestational diabetes mellitus pregnancies. Diabetes. 2020;69(Supplement1):1972–P. doi:10.2337/db20-1972-P
   Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl1):S11–s24. doi:10.2337/dc17-S005
   PubMedGoogle Scholar
• Rani PR, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagnostic Res. 2016;10(4):Qe01–4. doi:10.7860/jcdr/2016/17588.7689
   PubMed Web of Science ®Google Scholar
• Sweeting A, Park F, Hyett J. The first trimester: prediction and prevention of the great obstetrical syndromes. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):183–193. doi:10.1016/j.bpobgyn.2014.09.006
   Web of Science ®Google Scholar
• Zhang H, Luan S, Xiao X, Lin L, Zhao X, Liu X. Silenced microRNA-222 suppresses inflammatory response in gestational diabetes mellitus mice by promoting CXCR4. Life Sci. 2021;266:118850. doi:10.1016/j.lfs.2020.118850
   Web of Science ®Google Scholar
• Chen SH, Liu XN, Peng Y. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus. J Cell Mol Med. 2019;23(9):5895–5906. doi:10.1111/jcmm.14079
   PubMed Web of Science ®Google Scholar
• Zhao H, Tao S. MiRNA-221 protects islet β cell function in gestational diabetes mellitus by targeting PAK1. Biochem Biophys Res Commun. 2019;520(1):218–224. doi:10.1016/j.bbrc.2019.09.139
   Web of Science ®Google Scholar
• Zhao C, Zhao C, Zhao H. Defective insulin receptor signaling in patients with gestational diabetes is related to dysregulated miR-140 which can be improved by naringenin. Int J Biochem Cell Biol. 2020;128:105824. doi:10.1016/j.biocel.2020.105824
   PubMed Web of Science ®Google Scholar
• Xiao Y, Chen W, Chen R, et al. Exosomal microRNA expression profiling analysis of the effects of Lycium barbarum polysaccharide on gestational diabetes mellitus mice. Evid Based Complement Alternat Med. 2020;2020:2953502. doi:10.1155/2020/2953502
   PubMed Web of Science ®Google Scholar